Abstract |
SJG-136 ( NSC 694501) is a novel DNA cross-linking agent that binds in a sequence-selective manner in the minor groove of the DNA helix. It is structurally novel compared with other clinically used DNA cross-linking agents and has exhibited a unique multilog differential pattern of activity in the NCI 60-cell line screen (i.e., is COMPARE negative to other cross-linking agents). Given this profile, we undertook a preclinical evaluation of SJG-136 in primary tumor cells derived from 34 B-cell chronic lymphocytic leukemia (B-CLL) patients. SJG-136 induced apoptosis in all of the B-CLL samples tested with a mean LD50 value (the concentration of drug required to kill 50% of the cells) of 9.06 nmol/L. Its cytotoxicity was undiminished in B-CLL cells derived from patients treated previously, those with unmutated VH genes, and those with p53 mutations (P=0.17; P=0.63; P=0.42, respectively). SJG-136-induced apoptosis was associated with the activation of caspase-3 that could be partially abrogated by the caspase-9 inhibitor Z-LEHD-FMK. Furthermore, SJG-136 did not trigger the phosphorylation of p53 or the up-regulation of GADD45 expression in B-CLL cells whereas the cross-linking agent chlorambucil elicited both of these effects. This suggests that SJG-136 cross-linking adducts are not subject to p53-mediated DNA excision repair mechanisms in B-CLL cells. Taken together, these data demonstrate a novel mechanism of action for SJG-136 that appears to circumvent the effects of poor prognostic markers. This unique cytotoxicity profile warrants further investigation and supports the evaluation of this agent in Phase I clinical trials for patients with B-CLL.
|
Authors | Christopher J Pepper, Rachel M Hambly, Christopher D Fegan, Patrick Delavault, David E Thurston |
Journal | Cancer research
(Cancer Res)
Vol. 64
Issue 18
Pg. 6750-5
(Sep 15 2004)
ISSN: 0008-5472 [Print] United States |
PMID | 15374993
(Publication Type: Journal Article)
|
Chemical References |
- 1,1'-((propane-1,3-diyl)dioxy)bis(7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5,11-dione)
- Benzodiazepinones
- Cross-Linking Reagents
- Pyrroles
- Tumor Suppressor Protein p53
- Benzodiazepines
- CASP3 protein, human
- Caspase 3
- Caspases
- Vidarabine
- fludarabine
|
Topics |
- Apoptosis
(drug effects)
- B-Lymphocytes
(cytology, drug effects, pathology)
- Benzodiazepines
(pharmacology)
- Benzodiazepinones
(pharmacology)
- Case-Control Studies
- Caspase 3
- Caspases
(metabolism)
- Cross-Linking Reagents
(pharmacology)
- DNA Damage
- DNA Repair
- Enzyme Activation
- Humans
- K562 Cells
- Leukemia, Lymphocytic, Chronic, B-Cell
(blood, drug therapy, genetics, pathology)
- Pyrroles
(pharmacology)
- T-Lymphocytes
(cytology, drug effects, pathology)
- Tumor Cells, Cultured
- Tumor Suppressor Protein p53
(physiology)
- Vidarabine
(analogs & derivatives, pharmacology)
|